LRI Advocates for FDA Legislation to Accelerate New Lupus Treatments
Tuesday, June 19, 2012
The Lupus Research Institute and its Coalition of patient groups throughout the country sent the attached letter to key senators and congress people for inclusion of provisions in new FDA legislation that will accelerate the delivery of lifesaving and life enhancing treatments for individuals affected by autoimmune diseases of unmet need such as lupus.
On the go?
Text INFO to 50555 and opt-in to receive breaking news about lupus on your mobile phone.
Message and Data Rates May Apply. Text STOP to 50555 to STOP. Text HELP to 50555 for HELP. Full Terms